Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drug Information Medical Encyclopedia Dictionary News Directories Other Resources

Other drug names: A-Am  An-Az  B  C-Ch  Ci-Cz  D-Dh  Di-Dz  E  F  G  H  I-J  K-L  M-Mh  Mi-Mz  N-Nh  Ni-Nz  O  P-Pl  Pm-Pz  Q-R  S-Sn  So-Sz  T-To  Tp-Tz  U-V  W-Z  0-9

Antihemophilic Factor (Recombinant)

Printer-friendly versionE-mail this page to a friend
(an tee hee moe fil' ik) (fak tir) (ree kom bi nant)

Brand name(s): Bioclate; Helixate; Kogenate; Recombinate
Other name(s): AHF; Factor VIII (Recombinant)

Contents of this page:

About your treatment

Your doctor has ordered antihemophilic factor (recombinant) to help your blood to clot. The drug will be either injected directly into your vein or added to an intravenous fluid that will drip through a needle or catheter placed in your vein for approximately 5-10 minutes. It may be given as often as two or three times daily or only occasionally, such as once every two or more weeks.

Antihemophilic factor (recombinant), a synthetic version of substances naturally produced by the body, activates substances in your blood to form clots and decrease bleeding episodes. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Your health care provider (doctor, nurse, or pharmacist) may measure the effectiveness and side effects of your treatment using laboratory tests and physical examinations. It is important to keep all appointments with your doctor and the laboratory. The length of treatment depends on how your symptoms respond to the medication.

Precautions

Before administering antihemophilic factor (recombinant),

Administering your medication

Before you administer antihemophilic factor (recombinant), look at the solution closely. It should be clear and free of floating material. Gently squeeze the bag or observe the solution container to make sure there are no leaks. Do not use the solution if it is discolored, if it contains particles, or if the bag or container leaks. Use a new solution, but show the damaged one to your health care provider.

It is important that you use your medication exactly as directed. Do not stop your therapy on your own for any reason. Do not change your dosing schedule without talking to your health care provider. Your health care provider may tell you to stop your infusion if you have a mechanical problem (such as a blockage in the tubing, needle, or catheter); if you have to stop an infusion, call your health care provider immediately so your therapy can continue.

Side effects

Although side effects from antihemophilic factor (recombinant) are not common, they can occur. Tell your health care provider if any of these symptoms are severe or do not go away:

If you experience any of the following symptoms, stop your infusion and call your health care provider immediately:

Storing your medication

Store your medication only as directed. Make sure you understand what you need to store your medication properly.

Keep your supplies in a clean, dry place when you are not using them, and keep all medications and supplies out of reach of children. Your health care provider will tell you how to throw away used needles, syringes, tubing, and containers to avoid accidental injury.

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Signs of infection

If you are receiving antihemophilic factor (recombinant) in your vein or under your skin, you need to know the symptoms of a catheter-related infection (an infection where the needle enters your vein or skin). If you experience any of these effects near your intravenous catheter, tell your health care provider as soon as possible:

Last Revised - 01/01/2003


ASHP Logo
American Society of Health-System Pharmacists, Inc. Disclaimer

The MedMaster™ Patient Drug Information database provides information copyrighted by the American Society of Health-System Pharmacists, Inc., Bethesda, Maryland Copyright© 2004. All Rights Reserved.